AURIS MEDICAL HOLDING

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	EARS
ISIN:	CH0249375764

AURIS MEDICAL HOLDING overview

AURIS MEDICAL HOLDING > News GlobeNewsWire published a news.

Auris Medical Announces Launch of New Corporate Website • • GlobeNewsWire • Stocks • More AURIS MEDICAL HOLDING news...

Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the launch of its newly-designed corporate website www.aurismedical.com . The new website features a streamlined and modern design and also reflects the Company’s recently announced strategic repositioning. “We are proud to present our projects and...

Thank you

AURIS MEDICAL HOLDING > News GlobeNewsWire published a news.

Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2 • • GlobeNewsWire • Stocks • More AURIS MEDICAL HOLDING news...

Bentrio™ formulation well tolerated in vitro on human nasal epithelium Up to 99% reduction of SARS-CoV-2 viral titer with prophylactic treatment vs. controls Viral titer reduced 12- or 14-fold vs. controls when treatment started 24 or 30 h post infection Hamilton, Bermuda, July 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced...

Thank you

AURIS MEDICAL HOLDING > News GlobeNewsWire published a news.

Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology • • GlobeNewsWire • Stocks • More AURIS MEDICAL HOLDING news...

Treatment of KRAS-driven colorectal cancer selected as first therapeutic indication for OligoPhore™ platform Company to launch development program under project code AM-401 with aim of IND submission in late 2022 Hamilton, Bermuda, July 6, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the selection of mutant KRAS-driven...

Thank you

AURIS MEDICAL HOLDING > News GlobeNewsWire published a news.

Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany • • GlobeNewsWire • Stocks • More AURIS MEDICAL HOLDING news...

Hamilton, Bermuda, June 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced that its affiliate Altamira Medica Ltd. will start the market roll-out of Bentrio™, its nasal spray for protection against airborne viruses and allergens, by launching it in Germany. Bentrio™ will shortly become available through selected online...

Thank you

AURIS MEDICAL HOLDING > Analyses

Londinia AI has published a new analysis for aba0550.

0
72993
15111
0

AURIS MEDICAL HOLDING - 1H

Timeframe : 1H - Simple chart
Status : INVALID

All elements being clearly bearish, it would be possible for traders to trade only short positions (for sale) on AURIS MEDICAL HOLDING as long as the price remains well below 3.35 USD. The sellers'…

Thank you Reply

AURIS MEDICAL HOLDING > Analyses

Londinia AI has published a new analysis for aba0550.

0
72993
15111
0

AURIS MEDICAL HOLDING - Daily

Timeframe : Daily - Simple chart
Status : INVALID

The short-term decline is currently reinforcing the basic trend, which is only slightly bearish. It would be possible for traders to only trade short positions (for sale) on AURIS MEDICAL HOLDING as…

Thank you Reply

AURIS MEDICAL HOLDING > Analyses

Londinia AI has published a new analysis for aba0550.

0
72993
15111
0

AURIS MEDICAL HOLDING - 15 min.

Timeframe : 15 min. - Simple chart
Status : INVALID

We are currently in a phase of short-term indecision. In a case like this, you could favour trades in the direction of the basic trend on AURIS MEDICAL HOLDING. As long as you are under the resistance…

Thank you Reply

AURIS MEDICAL HOLDING > News GlobeNewsWire published a news.

Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma • • GlobeNewsWire • Stocks • More AURIS MEDICAL HOLDING news...

Treatment with OligoPhore TM siRNA stops aggressive ATLL tumor growth to near zero Significant reduction in tumor size, spleen size and peripheral blood lymphocyte counts Results add to extensive body of evidence for effective OligoPhore TM enabled delivery of nucleic acids to extrahepatic tissues Hamilton, Bermuda, June 21, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,...

Thank you

Load more content